Jun. 8 at 4:44 PM
$HUMA I have a great one for you! This is such a clean ticker with a massive explosion coming up!
$HUMA On June 11, 2026. Humacyte will present its V012 Phase 3 clinical trial readout for its Acellular Tissue Engineered Vessel (ATEV) in hemodialysis access live at the Vascular Annual Meeting
Plus phase 3 showed good results, so likely this gets approved and going. Also, on May 20, 2026, a ''high-profile'' corporate director executed a large open-market share purchase, signaled by a Form 4 filing just weeks ahead of the critical Phase 3 presentation
It has just about doubled since that executive buy, for a reason. @LosersMakeMillions @DavidScott
$VIGI $GRRR